Status:
TERMINATED
TissuePAtchDS--P ™ PArotidectomy Trial.
Lead Sponsor:
Poole Hospital NHS Foundation Trust
Conditions:
Parotid Gland Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The parotid (salivary) gland can develop growths (tumours), most of which are not cancerous but may develop into a cancer if left untreated. Tumours located near the surface of the gland are surgicall...
Detailed Description
The parotid (salivary) gland can develop growths (tumours), most of which are not cancerous but may develop into a cancer if left untreated. Tumours located near the surface of the gland are surgicall...
Eligibility Criteria
Inclusion
- All patients undergoing superficial parotidectomy for benign parotid disease.
- Patients 18 years of age or above.
Exclusion
- American Society of Anesthesiologists (ASA) classification \>2 and/or Body Mass Index (BMI) \>35.
- Any patient with malignant, infected/inflamed or recurrent parotid disease.
- Patients taking immunosuppressants.
- Patients with a history of allergic reaction to the composites of the patch
- Previous parotid surgery to the same side.
Key Trial Info
Start Date :
November 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04116762
Start Date
November 30 2018
End Date
October 1 2019
Last Update
October 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poole Hospital NHSFT
Poole, Dorset, United Kingdom, BH15 2JB